Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients
Clinical trial NCT02239835 · TERMINATED
Trial details
- NCT number
- NCT02239835
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2001-11-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.